Progress Through Unity

Archives for October 14, 2021

Update on NJ TRANSIT Full Return to Worksites

Alternate text

 

ATTENTION EMPLOYEES

 

Phase 3 of NJ TRANSIT’s return to the workplace plan – where employees are required to come back to the workplace full time, five days a week – will now begin on Monday, November 8th, 2021.

As a result, NJ TRANSIT will extend Phase 2 of its return to the workplace plan – where employees are required to come into the workplace at least two times a week – through Friday, November 5th.

However, all NJ TRANSIT employees are still required to be fully vaccinated against the virus that causes COVID-19 by October 18th, 2021, or to undergo regular testing, once the plans for testing have been finalized and communicated in the coming days. 

Employees can securely submit proof of vaccination status (copy of CDC card, screenshot of Docket App, NJIIS vaccination record) to the following email: COVIDVAXProof@njtransit.com. You must include your employee ID number in the subject line of your email.

Please visit covid19.nj.gov/finder for up-to-date vaccine locations in New Jersey.

Testing procedures for those unvaccinated by October 18th will be coming shortly.

 

Brian A. Lapp

SVP & Chief Safety Officer

NJ TRANSIT

Office: (973) 491-7942

Mobile: (973) 558-1405

BLapp@NJTransit.com

Employee Message from President & CEO Kevin Corbett – October 13, 2021

Dear Colleagues,

 

Yesterday the NJ TRANSIT Board of Directors approved an historic construction award to Skanska Traylor PNB Joint Venture in the amount of $1,559,993,000 for our Portal North Bridge Replacement Project – the single largest construction contract award in our agency’s history! The new Portal North Bridge will span nearly three miles of the Northeast Corridor, and includes the construction of retaining walls, deep foundations, concrete piers, structural steel bridge spans, rail systems, and demolition of the existing bridge.

This is a proud moment for all of us. It represents the culmination of more than three years of hard work and determination by NJ TRANSIT and our project partners at Amtrak. It also means that very soon, we will begin construction on a project of national significance – creating jobs and spurring economic growth for our region, and restoring dependable rail service to the millions of customers who count on this critical link between New Jersey and New York every year.

 

For a project of this magnitude – spanning so many different departments, including Capital Programs, Procurement, Finance, Operations, Office of Business Development and many others – it would be impossible for me to individually thank every employee who directly contributed to our success. I would, however, like to offer my sincere gratitude to every NJ TRANSIT employee, because this project is truly an organization-wide effort, and we all deserve to feel a sense of accomplishment today. This project will not only create approximately 15,000 jobs and add billions of dollars to our economy, but it will vastly improve the experience for all our customers commuting between New Jersey and New York, along with Amtrak’s customers between Washington, D.C. and Boston, for generations to come

Once again, thank you all for your efforts to turn the vision we had for this critical infrastructure project into a reality.

Warmly,

 

Kevin

 

Vaccination/Testing

To all- I want to give you an update on the latest vaccine and testing protocols. As you know, all employees are required to either be vaccinated (and show proof of their vaccination status) or be subject to testing.

Employees who are vaccinated should  forward a copy of their vaccine card to Covidvaxproof@njtransit.com
Employees must provide their name and employee number on the subject line of the email. Once received, the employee will receive a confirmation via email. Vaccination cards should be submitted by Monday, October 18, 2021. 

Given the complexity of developing a test procedure for a railroad environment, we have not finalized the scope and nature of the testing process.  As soon as a testing procedure is developed, we will  share it with you and answer questions you may have. 

We appreciate your patience as this process is developed. 


General Chairman/President Smart-TD Local 60/GO-610
8 Wilson Ave 3rd Fl
Newark, N.J. 07060
Office: 973-527-7020
Cell: 908-294-0166